Hains Guy, Descarreaux Martin, Lamy Anne-Marie, Hains François
Private practice.
J Can Chiropr Assoc. 2010 Sep;54(3):155-63.
Randomized clinical trial.
The aim of this study was to evaluate the effect of ischemic compression therapy in the treatment of chronic carpal tunnel syndrome.
Fifty-five patients suffering from carpal tunnel syndrome were randomized to two groups. Thirty-seven patients received 15 experimental treatments which consisted of ischemic compressions at trigger points located in the axilla of the shoulder, the length of the biceps muscle, at the bicipital aponeurosis and at the pronator teres muscle in the hollow of the elbow. Eighteen patients received the control treatment involving ischemic compression on trigger points located in the deltoid muscle, supraspinatus muscle and infraspinatus muscle. Of the 18 patients forming the control group, 13 agreed to receive the experimental treatments after the 15 control treatments. Outcome measures included a validated 18-question questionnaire to assess the severity of symptoms and functional status in carpal tunnel syndrome, and a quantification of the patients' perceived improvement, using a scale from 0% to 100%. Outcome measures evaluations were completed at baseline, after 15 treatments, 30 days following the last treatment, and 6 months later.
For the disability questionnaire, a significant reduction of symptoms was noted only in the experimental group. In the experimental group the outcome at baseline was 33.5 (SD, 10.3); after 15 treatments it was 18.6 (SD, 7.0). The control group outcome at baseline was 36.3 (SD, 15.2); after 15 treatments it was 26.4 (SD, 9.9) and after the crossover (15 control treatments plus 15 experimental treatments) 20.2 (SD, 12.2). A significant between group difference (P < 0.021) was noted in the patients' perceived improvement after 15 treatments: 67 (SD, 26) percent and 50 (SD, 25) percent respectively for the experimental and control groups.
This practice-based clinical trial suggests that myofascial therapy using ischemic compression the length of the biceps, at the bicipital aponeurosis, at the pronator teres and at the subscapularis muscles could be a useful approach to reduce symptoms associated with the carpal tunnel syndrome. Patients' perceived improvement in functional capacities persisted over a 6-month period.
随机临床试验。
本研究旨在评估缺血性压迫疗法对慢性腕管综合征的治疗效果。
55例腕管综合征患者被随机分为两组。37例患者接受15次实验性治疗,包括对位于肩部腋窝、肱二头肌长度、肱二头肌腱膜及肘部凹陷处旋前圆肌的触发点进行缺血性压迫。18例患者接受对照治疗,即对位于三角肌、冈上肌和冈下肌的触发点进行缺血性压迫。在组成对照组的18例患者中,13例在接受15次对照治疗后同意接受实验性治疗。疗效指标包括一份经过验证的18项问卷,用于评估腕管综合征的症状严重程度和功能状态,以及使用0%至100%的量表对患者自我感觉的改善程度进行量化。疗效指标评估在基线、15次治疗后、最后一次治疗后30天及6个月后完成。
对于残疾问卷,仅在实验组中观察到症状有显著减轻。在实验组中,基线时的结果为33.5(标准差,10.3);15次治疗后为18.6(标准差,7.0)。对照组基线时的结果为36.3(标准差,15.2);15次治疗后为26.4(标准差,9.9),在交叉治疗(15次对照治疗加15次实验性治疗)后为20.2(标准差,12.2)。在15次治疗后,两组患者自我感觉的改善程度存在显著差异(P < 0.021):实验组和对照组分别为67(标准差,26)%和50(标准差,25)%。
这项基于实践的临床试验表明,对肱二头肌长度、肱二头肌腱膜、旋前圆肌和肩胛下肌进行缺血性压迫的肌筋膜疗法可能是减轻腕管综合征相关症状的一种有效方法。患者自我感觉的功能能力改善在6个月内持续存在。